India has allowed commercial export of Covid-19 vaccines being manufactured in the country from Friday. Brazil and Morocco will be the first two countries that are getting the commercial contracted supplies of 20 lakh doses each with flights leaving at 4.15 am IST and 8 am IST, respectively tomorrow.
Reuters that will send the doses of the Oxford / AstraZeneca vaccine to Brazil purchased by the federal government, it was the Ministry of Health announce the completion of the import. In a note, the folder confirmed the arrival date of the immunizers: in the late afternoon of this Friday (22). The cargo coming from India will be transported on a commercial flight by the Emirates company to Guarulhos airport (SP) and, after customs formalities, it will continue on a Azul aircraft to Tom Jobim international airport, in Rio de Janeiro , explains the note from Ministry of Health.
advertising
O @minsaude reports that the 2 million doses of @AstraZeneca should arrive in Brazil Friday 22. The cargo coming from India will be transported by @emirates Guarulhos airport. After customs formalities, you will continue in flight from @blackpink to Tom Jobim airport, in RJ# COVID19- Ministério da Saúde (@minsaude) January 21, 2021
India allows commercial export of COVID vaccines from Friday; first stop Brazil, Morocco
Brazil and Morocco will be the first two countries that are getting the commercial contracted supplies of 20 lakh doses each, of COVID-19 vaccines. An employee removes vials of AstraZeneca s COVISHIELD vaccine from a visual inspection machine inside a lab at Serum Institute of India, in Pune. (File photo: Reuters)
Share
Updated: Jan 21, 2021, 11:50 PM IST
India has allowed the commercial export of COVID-19 vaccines from Friday, that are manufactured in the country. Brazil and Morocco will be the first two countries that are getting the commercial contracted supplies of 20 lakh doses each with flights leaving at 4.15 am IST and 8 am IST, respectively on Friday.
COVID-19 cross-protection? When vaccines provide bonus protection against other diseases
Posted
TueTuesday 19
JanJanuary 2021 at 8:03pm
COVID-19 vaccines are being rolled out in their millions. While they show high rates of protection against the disease, could they stave off the pesky common cold too?
(
Share
Print text only
Cancel
Those of us who avoided COVID-19 over the past year may be somewhat surprised to learn there s a good chance we ve already been infected by at least one coronavirus.
They re thought to be behind up to a third of all common colds. And intriguingly, evidence emerged last year that suggested people who were previously exposed to a common cold coronavirus might have some protection against COVID-19.